Stock & Company Details
Abeona Therapeutics Inc $ABEO
Price:
N/A
N/A
57M
$260M
52 Week High:
N/A
10 Day Average Volume:
N/A
5.27
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABEO technical indicators
Latest Abeona Therapeutics Inc (ABEO) indicator readings as of 2026-10-29.
ABEO's 14-day RSI is 41.2, in neutral territory. At $4.56 it is trading 17.1% below its 200-day moving average of $5.50, and below its 50-day average of $5.28. Price sits in the middle of its Bollinger Bands ($4.13 to $5.19). ADX reads 29.2, indicating a trending market.
Overview
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.
Finance Bot
Ask your questions
Start by typing a question below.
